MedPath

Evaluate the effect of modified kushthaghna kwath and tutthadi lepa in skin disorder(dadru kushtha)

Phase 2
Not yet recruiting
Conditions
Tinea corporis. Ayurveda Condition: DADRU-KUSHTHAH,
Registration Number
CTRI/2022/07/043946
Lead Sponsor
National Institute of Ayurveda Jaipur
Brief Summary

Recurrence is common with major side effects for overcoming adverse consequences need arises to go to natural herbal remedies. Hence, it is necessary to study and reinterpret the effect of drugs mentioned in Ayurveda classics and asses its efficacy particularly in this condition. After reviewing the literature keeping in mind the limitations of current standard treatment, two drugs has been selected which are supposed to be effective in conditions similar to *Dadru Kushta* with special reference to Tinea corporis. In the present clinical trial efficacy of Modified *Kushthaghna Mahakashaya kwath and tutthadi lepa* will be evaluated in the management of *Dadru Kushtha* with special reference to  Tinea Corporis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria
  • 1.Patient willing to participate in clinical trial.
  • 2.The patients of either sex having age between 18 -60 years.
  • 3.The patients having clinical signs and symptoms of Dadru Kushtha with special reference to Tinea Corporis 4.Patients with chronicity of illness < 5years.
Exclusion Criteria
  • 1.Patients with long-term history of steroid and cytotoxic treatment.
  • 2.Patients having concomitant illness like uncontrolled Hypertension, Diabetes Mellitus and known case of HIV, Malignancy.
  • 3.Patients having other associated skin disease like eczema, secondary bacterial infection, etc.
  • 4.Patient participated in any clinical trial with in last six months.
  • 5.Pregnant or lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Kandu (Itching)30 Days
2.Raga (Color)30 Days
3.Mandala (Elevated Margin)30 Days
Secondary Outcome Measures
NameTimeMethod
1.Mandala (No of Lesions)2.Mandal (Size of Lesion)

Trial Locations

Locations (1)

National Institute of Ayurveda,Jaipur and associated hospitals

🇮🇳

Jaipur, RAJASTHAN, India

National Institute of Ayurveda,Jaipur and associated hospitals
🇮🇳Jaipur, RAJASTHAN, India
VIJAY KUMARI SHARMA
Principal investigator
9587559406
vijaysharmavjvj@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.